Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

An integrated transcriptomic and meta-analysis of hepatoma cells reveals factors that influence susceptibility to HCV infection.

MacPherson JI, Sidders B, Wieland S, Zhong J, Targett-Adams P, Lohmann V, Backes P, Delpuech-Adams O, Chisari F, Lewis M, Parkinson T, Robertson DL.

PLoS One. 2011;6(10):e25584. doi: 10.1371/journal.pone.0025584. Epub 2011 Oct 25.

2.

HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.

Israelow B, Narbus CM, Sourisseau M, Evans MJ.

Hepatology. 2014 Oct;60(4):1170-9. doi: 10.1002/hep.27227. Epub 2014 Aug 21.

3.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
4.

Permissiveness of human hepatoma cell lines for HCV infection.

Sainz B Jr, Barretto N, Yu X, Corcoran P, Uprichard SL.

Virol J. 2012 Jan 24;9:30. doi: 10.1186/1743-422X-9-30.

5.

RNA-Seq-based analysis of differential gene expression associated with hepatitis C virus infection in a cell culture.

Hojka-Osinska A, Budzko L, Zmienko A, Rybarczyk A, Maillard P, Budkowska A, Figlerowicz M, Jackowiak P.

Acta Biochim Pol. 2016;63(4):789-798. Epub 2016 Oct 25.

6.

Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a.

Manzoor S, Idrees M, Ashraf J, Mehmood A, Butt S, Fatima K, Akbar H, Rehaman IU, Qadri I.

Virol J. 2011 Sep 8;8:431. doi: 10.1186/1743-422X-8-431.

7.

Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.

Inoue Y, Murakami K, Hmwe SS, Aizaki H, Suzuki T.

Jpn J Infect Dis. 2007 Jul;60(4):173-8.

8.

Hepatitis virus infection affects DNA methylation in mice with humanized livers.

Okamoto Y, Shinjo K, Shimizu Y, Sano T, Yamao K, Gao W, Fujii M, Osada H, Sekido Y, Murakami S, Tanaka Y, Joh T, Sato S, Takahashi S, Wakita T, Zhu J, Issa JP, Kondo Y.

Gastroenterology. 2014 Feb;146(2):562-72. doi: 10.1053/j.gastro.2013.10.056. Epub 2013 Oct 30.

PMID:
24184133
9.

Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.

Zhang Q, Wei L, Yang H, Yang W, Yang Q, Zhang Z, Wu K, Wu J.

Cancer Lett. 2016 Feb 1;371(1):107-16. doi: 10.1016/j.canlet.2015.11.027. Epub 2015 Nov 24.

10.
11.

Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.

Sarhan MA, Chen AY, Russell RS, Michalak TI.

J Gen Virol. 2012 Nov;93(Pt 11):2399-407. doi: 10.1099/vir.0.045393-0. Epub 2012 Aug 1.

PMID:
22855787
12.

Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.

Eyre NS, Phillips RJ, Bowden S, Yip E, Dewar B, Locarnini SA, Beard MR.

J Hepatol. 2009 Sep;51(3):446-57. doi: 10.1016/j.jhep.2009.04.025. Epub 2009 Jun 3.

PMID:
19596477
13.

An occult hepatitis B-derived hepatoma cell line carrying persistent nuclear viral DNA and permissive for exogenous hepatitis B virus infection.

Lin CL, Chien RN, Lin SM, Ke PY, Lin CC, Yeh CT.

PLoS One. 2013 May 29;8(5):e65456. doi: 10.1371/journal.pone.0065456. Print 2013.

14.

Host cell responses induced by hepatitis C virus binding.

Fang X, Zeisel MB, Wilpert J, Gissler B, Thimme R, Kreutz C, Maiwald T, Timmer J, Kern WV, Donauer J, Geyer M, Walz G, Depla E, von Weizsäcker F, Blum HE, Baumert TF.

Hepatology. 2006 Jun;43(6):1326-36.

15.

Interferon Response in Hepatitis C Virus (HCV) Infection: Lessons from Cell Culture Systems of HCV Infection.

Sung PS, Shin EC, Yoon SK.

Int J Mol Sci. 2015 Oct 7;16(10):23683-94. doi: 10.3390/ijms161023683. Review.

16.

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

Stegmann KA, Björkström NK, Ciesek S, Lunemann S, Jaroszewicz J, Wiegand J, Malinski P, Dustin LB, Rice CM, Manns MP, Pietschmann T, Cornberg M, Ljunggren HG, Wedemeyer H.

J Infect Dis. 2012 May 1;205(9):1351-62. doi: 10.1093/infdis/jis210. Epub 2012 Mar 29.

17.

Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.

Fénéant L, Ghosn J, Fouquet B, Helle F, Belouzard S, Vausselin T, Séron K, Delfraissy JF, Dubuisson J, Misrahi M, Cocquerel L.

PLoS One. 2015 Nov 12;10(11):e0142539. doi: 10.1371/journal.pone.0142539. eCollection 2015.

18.

Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Ali N, Allam H, May R, Sureban SM, Bronze MS, Bader T, Umar S, Anant S, Houchen CW.

J Virol. 2011 Dec;85(23):12292-303. doi: 10.1128/JVI.05920-11. Epub 2011 Sep 21.

19.

Hepatitis C virus replication and Golgi function in brefeldin a-resistant hepatoma-derived cells.

Farhat R, Goueslain L, Wychowski C, Belouzard S, Fénéant L, Jackson CL, Dubuisson J, Rouillé Y.

PLoS One. 2013 Sep 18;8(9):e74491. doi: 10.1371/journal.pone.0074491. eCollection 2013.

20.

Permissivity of primary human hepatocytes and different hepatoma cell lines to cell culture adapted hepatitis C virus.

Helle F, Brochot E, Fournier C, Descamps V, Izquierdo L, Hoffmann TW, Morel V, Herpe YE, Bengrine A, Belouzard S, Wychowski C, Dubuisson J, Francois C, Regimbeau JM, Castelain S, Duverlie G.

PLoS One. 2013 Aug 5;8(8):e70809. doi: 10.1371/journal.pone.0070809. Print 2013.

Supplemental Content

Support Center